These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 17271049)

  • 1. Directed evolution of AAV mutants for enhanced gene delivery.
    Schaffer DV; Maheshri N
    Conf Proc IEEE Eng Med Biol Soc; 2004; 2004():3520-3. PubMed ID: 17271049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutational analysis of the adeno-associated virus type 2 (AAV2) capsid gene and construction of AAV2 vectors with altered tropism.
    Wu P; Xiao W; Conlon T; Hughes J; Agbandje-McKenna M; Ferkol T; Flotte T; Muzyczka N
    J Virol; 2000 Sep; 74(18):8635-47. PubMed ID: 10954565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insertional mutagenesis of the adeno-associated virus type 2 (AAV2) capsid gene and generation of AAV2 vectors targeted to alternative cell-surface receptors.
    Shi W; Arnold GS; Bartlett JS
    Hum Gene Ther; 2001 Sep; 12(14):1697-711. PubMed ID: 11560765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the Adeno-Associated Virus 1 and 6 Sialic Acid Binding Site.
    Huang LY; Patel A; Ng R; Miller EB; Halder S; McKenna R; Asokan A; Agbandje-McKenna M
    J Virol; 2016 Jun; 90(11):5219-5230. PubMed ID: 26962225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AAV capsid engineering identified two novel variants with improved in vivo tropism for cardiomyocytes.
    Rode L; Bär C; Groß S; Rossi A; Meumann N; Viereck J; Abbas N; Xiao K; Riedel I; Gietz A; Zimmer K; Odenthal M; Büning H; Thum T
    Mol Ther; 2022 Dec; 30(12):3601-3618. PubMed ID: 35810332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient and selective AAV2-mediated gene transfer directed to human vascular endothelial cells.
    Nicklin SA; Buening H; Dishart KL; de Alwis M; Girod A; Hacker U; Thrasher AJ; Ali RR; Hallek M; Baker AH
    Mol Ther; 2001 Sep; 4(3):174-81. PubMed ID: 11545607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RGD inclusion in VP3 provides adeno-associated virus type 2 (AAV2)-based vectors with a heparan sulfate-independent cell entry mechanism.
    Shi W; Bartlett JS
    Mol Ther; 2003 Apr; 7(4):515-25. PubMed ID: 12727115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cryo-electron Microscopy Reconstruction and Stability Studies of the Wild Type and the R432A Variant of Adeno-associated Virus Type 2 Reveal that Capsid Structural Stability Is a Major Factor in Genome Packaging.
    Drouin LM; Lins B; Janssen M; Bennett A; Chipman P; McKenna R; Chen W; Muzyczka N; Cardone G; Baker TS; Agbandje-McKenna M
    J Virol; 2016 Oct; 90(19):8542-51. PubMed ID: 27440903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Designer gene delivery vectors: molecular engineering and evolution of adeno-associated viral vectors for enhanced gene transfer.
    Kwon I; Schaffer DV
    Pharm Res; 2008 Mar; 25(3):489-99. PubMed ID: 17763830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Capsid modifications overcome low heterogeneous expression of heparan sulfate proteoglycan that limits AAV2-mediated gene transfer and therapeutic efficacy in human ovarian carcinoma.
    Shi W; Hemminki A; Bartlett JS
    Gynecol Oncol; 2006 Dec; 103(3):1054-62. PubMed ID: 16870238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Directed evolution of adeno-associated virus yields enhanced gene delivery vectors.
    Maheshri N; Koerber JT; Kaspar BK; Schaffer DV
    Nat Biotechnol; 2006 Feb; 24(2):198-204. PubMed ID: 16429148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of capsid modifications by selected peptide ligands on recombinant adeno-associated virus serotype 2-mediated gene transduction.
    Naumer M; Popa-Wagner R; Kleinschmidt JA
    J Gen Virol; 2012 Oct; 93(Pt 10):2131-2141. PubMed ID: 22764318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adeno-associated Virus (AAV) Serotypes Have Distinctive Interactions with Domains of the Cellular AAV Receptor.
    Pillay S; Zou W; Cheng F; Puschnik AS; Meyer NL; Ganaie SS; Deng X; Wosen JE; Davulcu O; Yan Z; Engelhardt JF; Brown KE; Chapman MS; Qiu J; Carette JE
    J Virol; 2017 Sep; 91(18):. PubMed ID: 28679762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insertional mutagenesis at positions 520 and 584 of adeno-associated virus type 2 (AAV2) capsid gene and generation of AAV2 vectors with eliminated heparin- binding ability and introduced novel tropism.
    Shi X; Fang G; Shi W; Bartlett JS
    Hum Gene Ther; 2006 Mar; 17(3):353-61. PubMed ID: 16544984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rationally Engineered AAV Capsids Improve Transduction and Volumetric Spread in the CNS.
    Kanaan NM; Sellnow RC; Boye SL; Coberly B; Bennett A; Agbandje-McKenna M; Sortwell CE; Hauswirth WW; Boye SE; Manfredsson FP
    Mol Ther Nucleic Acids; 2017 Sep; 8():184-197. PubMed ID: 28918020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insertional mutagenesis of AAV2 capsid and the production of recombinant virus.
    Rabinowitz JE; Xiao W; Samulski RJ
    Virology; 1999 Dec; 265(2):274-85. PubMed ID: 10600599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraocular route of AAV2 vector administration defines humoral immune response and therapeutic potential.
    Li Q; Miller R; Han PY; Pang J; Dinculescu A; Chiodo V; Hauswirth WW
    Mol Vis; 2008 Sep; 14():1760-9. PubMed ID: 18836574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Marker rescue of adeno-associated virus (AAV) capsid mutants: a novel approach for chimeric AAV production.
    Bowles DE; Rabinowitz JE; Samulski RJ
    J Virol; 2003 Jan; 77(1):423-32. PubMed ID: 12477847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engineering a highly durable adeno-associated virus receptor for analytical applications.
    Yoshida K; Tsunekawa Y; Kurihara K; Watanabe K; Makino-Manabe Y; Wada M; Tanaka T; Ide T; Okada T
    Mol Ther Methods Clin Dev; 2023 Dec; 31():101157. PubMed ID: 38152699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-dressing the virion: the transcapsidation of adeno-associated virus serotypes functionally defines subgroups.
    Rabinowitz JE; Bowles DE; Faust SM; Ledford JG; Cunningham SE; Samulski RJ
    J Virol; 2004 May; 78(9):4421-32. PubMed ID: 15078923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.